Measuring the return from pharmaceutical innovation report 2022

Listen to episode twenty-three to hear Karen, and our guests dissect the findings from the latest annual R&D ROI Report which launched last month. This report has provided insights into the state of biopharma R&D since 2010. We have expanded the analysis over time and our data set now covers the top 20 pharma companies by R&D spend